Yunsong Tong

Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics

Zehan Chen, Zhan Xiao, Wen‐Zhen Gu et al. · International Journal of Cancer · 2006 · 129 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Synthesis and Evaluation of a New Generation of Orally Efficacious Benzimidazole-Based Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors as Anticancer Agents

Yunsong Tong, Jennifer J. Bouska, Eric F. Johnson et al. · Journal of Medicinal Chemistry · 2009 · 108 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies

Darren C. Phillips, Sha Jin, Gareth P. Gregory et al. · Leukemia · 2019 · 78 citations · Full text

Medicine, Oncology, Pharmacology +16

Conformationally Constrained Substance P Analogues:  The Total Synthesis of a Constrained Peptidomimetic for the Phe⁷-Phe⁸ Region

Yunsong Tong, Yvette M. Fobian, Meiye Wu et al. · The Journal of Organic Chemistry · 2000 · 72 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: Chemistry, biological activities, and molecular modeling

Yunsong Tong, Kent D. Stewart, Sheela A. Thomas et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 59 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17